Headline
The latest stories from AHA Today.
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart the administrative process for such a program.
The Coalition to Strengthen America’s Healthcare Feb. 5 released a new research brief examining the impact of proposed site-neutral payment policies on hospitals and patient access to care.
The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology announced the selection of nine pilots as part of the Behavioral Health Information Technology Initiative to help improve behavioral health data exchange across care settings.
The National Institute of Standards and Technology Feb. 2 published details on a critical vulnerability that impacted Notepad++, a free, open-source text and source code program widely used by several industries, including health care.
The AHA Feb. 5 announced WVU Medicine Potomac Valley Hospital in Keyser, W.Va., as the 2026 recipient of the new Rural Hospital Excellence in Innovation Award.
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and bipartisan health care challenges.
Carmela Coyle, California Hospital Association president and CEO, announced plans Feb. 5 to retire in early 2027, according to the CHA.
The Centers for Medicare & Medicaid Services Feb. 2 revised its approach to determining grandfathering eligibility by redefining the 180‑day window around July 4, 2025, to be calculated using business days.
The measles outbreak in South Carolina has increased to 876 cases, the state’s Department of Public Health reported Feb. 3. Last week, the South Carolina outbreak surpassed last year’s outbreak in Texas, which had 762 cases.
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are lower than actual blood glucose levels.